Takeda’s Eohilia Suffers Another Set Back FDA rejection after Mysterious Delay
Synopsis: -The FDA recommended Takeda run an additional clinical study to resolve its questions around Eohilia, an oral suspension formulation of the…
Synopsis: -The FDA recommended Takeda run an additional clinical study to resolve its questions around Eohilia, an oral suspension formulation of the…
Synopsis: After a special meeting, the Japanese drug reviewers ruled that existing data didn’t support an approval and are therefore seeking additional…
Synopsis: PDS Biotechnology Corporation (“PDS Biotechnology”) (Nasdaq: PDSB), a clinical-stage immuno-oncology company pioneering the development of novel multifunctional immunotherapeutic products, today announced…
Summary : Minim, Inc. the creator of intelligent networking products under the Motorola brand, announced that Sean Doherty will be transitioning from…
Summary : -New approvals are based on JUNIPERA trial data showing Cosentyx® (secukinumab) demonstrated reduced flare risk versus placebo and improvement in…
Synopsis : – Slalom Launch Center to help Japanese organizations accelerate cloud transformation and modernize their technology services Amazon Web Services…
Synopsis : Cabozantinib is used for the treatment of metastatic medullary thyroid cancer, advanced renal cell carcinoma and hepatocellular carcinoma, BDR Pharma…
Summary : The total outlay of the scheme as decided by the government is Rs.6,940 crore. The scheme will provide financial incentives…
Summary – BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ:BRTX), a life sciences company focused on adult stem cell-based therapies, today announced…
Summary – Launch of VYRA™ CoV2Flu Rapid Antigen Rapid Test (VYRA™ CoV2Flu). Based on MedMira’s proprietary technology, this 3-in-1 test is developed…